Sort
82,697 grants matching “vaccine development”
Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine
$712,297Jay Williams Hooper · Geneva Foundation · R01 · FY2015 · AI
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)AWARD OF TASK ORDER "OPTIMIZATION AND FURTHER DEVELOPMENT OF MESOTHELIN VACCINE FOR THE PREVENTION OF OVARIAN CANCER"
$712,240Nathalie Scholler · Sri International · N01 · FY2016 · CA
Genetic Epidemiology of Life-Threatening Influenza Infection in Children
$712,203Adrienne G Randolph · Boston Children'S Hospital · R56 · FY2009 · AI
Adolescent Medicine Trials Unit (AMTU) Network for HIV/*
$712,171John Barringer Steever · Icahn School Of Medicine At Mount Sinai · U01 · FY2008 · HD
Targeting cancer neoantigens in patients with myeloid malignancies
$712,168Vid Leko · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats
$712,070Natalie Exner Dean · Emory University · R01 · FY2021 · AI
Re-engineering gp120 to include glycan-dependent epitopes
$712,069Phillip Berman · University Of California Santa Cruz · R01 · FY2017 · AI
Bronx-Lebanon Hospital Clinical Trials Unit
$712,045Murli U Purswani · Bronxcare Health System · U01 · FY2008 · AI
Salmonella anti-influenza DNA & antigen delivery vaccine
$712,024Roy Curtiss · Arizona State University-Tempe Campus · R01 · FY2007 · AI
EdTech-HPV: A Community Approach using Education and Technology to Increase HPV Vaccination
$712,018Abraham Aragones · Sloan-Kettering Inst Can Research · R01 · FY2018 · MD
Development of Novel Antiviral Agents VS West Nile Virus
$712,013Washington University · U01 · FY2002 · AI
Motivational Interviewing Training to Promote COVID-19 and Influenza Vaccination (MI-VAX): What Providers Need and Patients Want
$712,013Kimberly Fisher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · MD
DEVELOPMENT OF A GPC2 CAR T CELL-AMPLIFYING EXTRACELLULAR VESICLE VACCINE
$712,000The Children'S Hospital Of Philadelphia · · FY2025 · Defense Health Agency
Mycobacterium tuberculosis disease effect on HIV-1 immunity, evolution, and persistence
$711,993Manish Sagar · Boston Medical Center · R56 · FY2025 · AI
Fusion inhibitors that block host-to-host transmission of SARS-CoV-2
$711,960Matteo Porotto · Columbia University Health Sciences · R01 · FY2024 · AI
NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT
$711,928Thomas Denny · Duke University · N01 · FY2018 · AI
Pediatric Respiratory Illness Measurement System (PRIMES) Implementation in Community Hospital Settings
$711,926Rita Mangione-Smith · Kaiser Foundation Research Institute · R01 · FY2022 · HL
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies
$711,873Rong Fan · Yale University · U01 · FY2022 · CA
Bivalent Recombinant LHn Botulinum Vaccine (Serotypes A and B)
$711,872Heidi Joyce Agostini · Emergent Product Development Gaithersbur · U01 · FY2008 · AI
Macaque Core -Core B
$711,797Vijayakumar Velu · Emory University · U19 · FY2017 · AI
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
$711,793Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses
$711,776Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Animal Core
$711,768James L Levin · Boston University Medical Campus · UC7 · FY2012 · AI
Developmental Core
$711,744Maria Blasi · Duke University · U54 · FY2022 · AI
Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats
$711,727Natalie Exner Dean · University Of Florida · R01 · FY2020 · AI